Viracta(VIRX) - 2020 Q1 - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (SNSS) Q1 2020 Earnings Conference Call May 7, 2020 4:30 PM ET Company Participants Par Hyare - Investor Relations Dayton Misfeldt - Interim Chief Executive Officer Judy Fox - Chief Scientific Officer, Executive Vice President, Research & Development Conference Call Participants Justin Kim - Oppenheimer Marc Frahm - Cowen Operator Ladies and gentlemen, thank you for standing by and welcome to Quarter First 2020 Sunesis Pharmaceutical Incorporated Earnings Conference Call. At th ...